May 30, 2023 | From the Labs Out with the Old (Neurons), In with the New New research from the Macklis lab finds that just a few thousand neurons orchestrate evolutionarily advanced forelimb and digit dexterity.
May 08, 2023 | From the Labs HDRB 2023 Graduate Thankful for HSCRB Support, Mentorship Reese Caldwell reflects back on his time in the HSCRB department
Mar 15, 2023 | From the Labs A 14-year Incubation In early 2023, Sam Wattrus, opened his own lab at Massachusetts General Hospital, becoming the first human developmental and regenerative biology concentrator to establish research lab
Feb 09, 2023 | Faculty Spotlight | From the Labs Meet the HSCRB Faculty: Ryan Flynn Ryan Flynn, MD, PhD, is an Assistant Professor in HSCRB and a Principal Investigator in the Stem Cell Program at Boston Children’s Hospital. Learn more about Ryan and his research below.
Sep 29, 2022 | From the Labs Brain organoids replicate key events in human brain development A single-cell analysis of 3D models of the human cerebral cortex suggests they can be used to study important brain processes that have been difficult to investigate
Aug 30, 2022 | From the Labs New technique reveals single cell gene regulatory networks Researchers can utilize this new framework to study how the epigenome influences gene expression in single cells over time
Mar 24, 2022 | From the Labs Improving stem cell-derived pancreatic cells with genetic engineering HSCRB scientists advance Type 1 diabetes therapy by protecting cells from immune attack and stress
Feb 02, 2022 | From the Labs Different autism risk genes, same effects on brain development HSCRB and Broad researchers use 3D, miniature models of the human brain to advance disease understanding
Dec 15, 2021 | From the Labs Genomic sequencing that preserves cells’ locations within tissues New technique allows researchers to better understand spatial differences in complex tissues such as tumors
Oct 20, 2021 | From the Labs A new therapy for treating Type 1 diabetes A stem-cell-derived replacement therapy shows unprecedented early results in treating Type 1 diabetes